
    
      The primary objective of this study is to evaluate the efficacy of intranasal administration
      of OPN-375 186 Î¼g Twice a Day (BID) versus placebo in adolescents with bilateral nasal
      polyposis and nasal congestion by analyzing the reduction of nasal congestion/obstruction
      symptoms at the end of Week 4 measured by the 7-day average instantaneous morning diary
      symptom scores and the reduction in total polyp grade at Week 16 as determined by a nasal
      polyp grading scale score measured using a 0 to 6 point severity grading scale.
    
  